Fuelling Further Growth of Biotech and Healthcare Industries: Leveraging Hong Kong’s Financial Infrastructure
15 Nov 2021
In recent years, governments around the world are putting increasing emphasis on healthcare- and biotechnology-related sectors, as longer life expectancy and better health conditions of citizens would not only mean a larger work force, but also enhanced overall social well-being. Serving as a reminder of the importance of such sectors, the recent global pandemic is seemingly urging the society to invest further into research and development (R&D) of relevant work. With the United Nations estimating that the population aged 65 or above will reach 1.5 billion by 2050, nearly doubling that in 2020,1 both public and private sectors have been stepping up allocation of resources, including financial resources, to healthcare and biotechnology sectors.